Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3186studies shown
Showing 3,126-3,150 of 3,186
WithdrawnNCT01779427

Attention Intervention Management

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 10 Years to 18 Years
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Condition
ADHD
CompletedNCT00844753

Atomoxetine, Placebo and Parent Management Training in Autism

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 5 Years to 14 Years
Countries
United States
Sponsor
University of Rochester
Condition
ADHD
CompletedNCT01161719

Effectiveness Study of Videoconferencing on Teaching Parent Training Skills to Parents of Children With Attention Deficit Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether the medication Videoconferencing offers something meaningfully different. Researchers are trying to understand whether the medication Videoconferencing can give earlier or clearer feedback during care.

ADHDOtherFrom 6 Years to 14 Years
Countries
United States
Sponsor
University of California, Davis
Condition
ADHD
CompletedNCT01876719

AR08 for Treatment of ADHD in Children

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.

ADHDOtherFrom 6 Years to 17 Years
Countries
United States
Sponsor
Arbor Pharmaceuticals, Inc.
Condition
ADHD
CompletedNCT01594606

Randomized Control Trial of an Animal-Assisted Intervention With Adjudicated Youth

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

AnxietyOtherFrom 14 Years to 17 Years
Countries
United States
Sponsor
Wayne State University
Condition
Anxiety
CompletedNCT00179894

Improving Attention Deficit Hyperactivity Disorder Treatment Adherence and Outcome in Primary Care Settings

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 11 Years
Countries
United States
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Condition
ADHD
CompletedNCT01369459

Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder

This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 13 Years to 17 Years
Countries
United States
Sponsor
The National Center on Addiction and Substance Abuse at Columbia University
Condition
ADHD
CompletedNCT01539941

Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD in Routine Care

This study exists to see whether psychoeducation, a guided learning and support program, is workable and worth testing more broadly. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 13 Years to 17 Years
Countries
United States
Sponsor
The National Center on Addiction and Substance Abuse at Columbia University
Condition
ADHD
CompletedNCT02225639

PRC-063 in an ADULT Workplace Environment

This study exists to compare options and see whether the medication PRC-063 offers something meaningfully different. Researchers are trying to understand whether the medication PRC-063 can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
CompletedNCT00151983

Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 12 Years
Countries
United States
Sponsor
Noven Therapeutics
Condition
ADHD
CompletedNCT02168127

Long-Term Safety of PRC-063 in Adolescents and Adults With ADHD

This study exists to understand how the medication PRC-063 holds up over time after the earliest research stage. Researchers are trying to understand whether the medication PRC-063 can improve attention, thinking, or day-to-day functioning.

ADHDOtherOver 12 Years
Countries
Canada, United States
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
CompletedNCT02139111

PRC-063 in Adolescent ADHD

This study exists to compare options and see whether the medication PRC-063 offers something meaningfully different. Researchers are trying to understand whether the medication PRC-063 can give earlier or clearer feedback during care.

ADHDOtherFrom 12 Years to 17 Years
Countries
Canada, United States
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
CompletedNCT00600470

Effectiveness of Collaborative Services in Primary Care for Treating Children With Behavior Disorders

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 5 Years to 12 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
ADHD
CompletedNCT00550147

Quetiapine and Concerta in the Treatment for ADHD and Aggressive Behavior.

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

ADHDOtherFrom 12 Years to 17 Years
Countries
United States
Sponsor
Indiana University
Condition
ADHD
WithdrawnNCT01858064

Predicting Treatment Response to Stimulants in Adult ADHD Using Functional Magnetic Resonance Imaging

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand what brain scans or other body measurements can reveal about signals in the brain or body that may guide care later on.

ADHDOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
CompletedNCT01463241

Behavioral and Affective Skills in Coping (BASIC) Open Trial

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand what helps a therapy or guided support program stay useful, realistic, and easier to follow over time.

DepressionOtherFrom 8 Years to 15 Years
Countries
United States
Sponsor
Judge Baker Children's Center
Condition
Depression
CompletedNCT01940978

A Study of Combination Therapy in Children With ADHD

This study exists to see whether the medication Combination can play a useful role in care. Researchers are trying to understand whether the medication Combination can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 12 Years
Countries
United States
Sponsor
Douglas Sears
Condition
ADHD
CompletedNCT02195167

Dasotraline SEP360-105 Pediatric PK/PD Study

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 17 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
United States | Clinical Trials | HopeStage Research